Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins - PubMed (original) (raw)

Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins

Na-Hye Myong. J Korean Med Sci. 2003 Aug.

Abstract

This study was aimed to evaluate the prevalence and prognostic implication of thyroid transcription factor-1 (TTF-1) immunoreactivity in 81 human lung carcinomas, including 65 cases of non-small cell lung carcinoma (NSCLC) and 16 cases of small cell lung carcinoma (SCLC); and also to investigate its relationship with the cell proliferation and regulation by immunostaining of Ki-67 and p53 proteins, respectively. The immunohistochemical staining for TTF-1 (clone 8G7G3/1) was performed and several clinicopathologic variables and the follow-up data were obtained. The immunostaining results for TTF-1 were semiquantitatively interpreted as negative and positive. Of NSCLCs, TTF-1 is highly expressed in adenocarcinomas (76%), whereas squamous cell carcinomas revealed no immunoreactivity (0%). SCLCs showed strong TTF-1 expression (88%). In NSCLC, TTF-1 expression was inversely correlated with Ki-67 proliferative activity and independent of p53 overexpression. TTF-1 (+) group tended to show better survival than TTF-1 (-) group in NSCLC. Conclusively, these observations suggest that TTF-1 is a sensitive and specific diagnostic marker for pulmonary adenocarcinomas and SCLCs; that TTF-1 might have a good prognostic implication based on its inverse correlation with Ki-67 proliferative activity and tendency for better survival in NSCLC; that this cell lineage marker may play a role in the molecular pathogenesis of lung cancers at the level of transcription.

PubMed Disclaimer

Cited by

Predicting Deep Learning Based Multi-Omics Parallel Integration Survival Subtypes in Lung Cancer Using Reverse Phase Protein Array Data.
Takahashi S, Asada K, Takasawa K, Shimoyama R, Sakai A, Bolatkan A, Shinkai N, Kobayashi K, Komatsu M, Kaneko S, Sese J, Hamamoto R. Takahashi S, et al. Biomolecules. 2020 Oct 19;10(10):1460. doi: 10.3390/biom10101460. Biomolecules. 2020. PMID: 33086649 Free PMC article.
Clinical significance of TTF-1 protein expression and TTF-1 gene amplification in lung adenocarcinoma.
Barletta JA, Perner S, Iafrate AJ, Yeap BY, Weir BA, Johnson LA, Johnson BE, Meyerson M, Rubin MA, Travis WD, Loda M, Chirieac LR. Barletta JA, et al. J Cell Mol Med. 2009 Aug;13(8B):1977-1986. doi: 10.1111/j.1582-4934.2008.00594.x. J Cell Mol Med. 2009. PMID: 19040416 Free PMC article.
[Research progress of thyroid transcription factor-1 as molecular marker in lung carcinoma].
Ge X, Jiang L. Ge X, et al. Zhongguo Fei Ai Za Zhi. 2014 Jun 20;17(6):491-5. doi: 10.3779/j.issn.1009-3419.2014.06.10. Zhongguo Fei Ai Za Zhi. 2014. PMID: 24949691 Free PMC article. Review. Chinese.
Value of thyroid transcription factor (TTF)-1 for diagnosis and prognosis of patients with locally advanced or metastatic small cell lung cancer.
Misch D, Blum T, Boch C, Weiss T, Crolow C, Griff S, Mairinger T, Bauer TT, Kollmeier J. Misch D, et al. Diagn Pathol. 2015 Apr 2;10:21. doi: 10.1186/s13000-015-0250-z. Diagn Pathol. 2015. PMID: 25889870 Free PMC article.
Thyroid transcription factor 1 represses the expression of Ki-67 and induces apoptosis in non-small cell lung cancer.
Zu YF, Wang XC, Chen Y, Wang JY, Liu X, Li X, Li CW, Xie YC, Luo Y, Shang XQ, Guo J. Zu YF, et al. Oncol Rep. 2012 Nov;28(5):1544-50. doi: 10.3892/or.2012.2009. Epub 2012 Aug 31. Oncol Rep. 2012. PMID: 22940844 Free PMC article.

Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins - PubMed (original) (raw)